MSK teams up with the LGBT Cancer Network and more…
- MSK hosted a conference on cancer in the LGBT community. In conjunction with the National LGBT Cancer Network, the conference, held at Memorial Sloan Kettering on Jan 18th, was attended by allied health professionals, students, researchers, clinicians and survivors. The intention of the conference was to provide attendees information about LGBT cancer risks and care of LGBT individuals, among other goals.
- Mark Kris, Chair in Thoracic Oncology at MSK recently discussed new drugs for lung cancer. One of the groups of drugs Dr. Kris talked about was antibody medications that are still in trials. They may provide significant benefits for lung cancer patients which so far, appear to be long lasting.
- MSK to collaborate with Sutro Biopharma to produce bispecific antibodies for treating neuroblastoma in children. MSK discovered these compounds and Sutro Biopharma will manufacture them. Once Sutra produces them, they will be tested by MSK using preclinical models.
- Company pledges money to support research through MSK’s Cycle for Survival event. Dzine, a digital communications firm, is supporting Nicholas Webb, a cancer survivor, who will be taking part in Cycle for Survival. This event raises money for pediatric cancer research at MSK.